AI Insight
Researchers have developed the first comprehensive capsule synthesis locus database specifically for the Klebsiella oxytoca Species Complex, an emerging group of healthcare-associated pathogens. The database contains 88 distinct genetic loci and successfully typed 97.6% of publicly available K. oxytoca genomes, significantly outperforming the existing Klebsiella database which only typed 50.3% of these genomes. Application to three clinical isolate collections demonstrated high diversity of capsule types within this bacterial species complex.
Why it matters
The capsule polysaccharide is a critical virulence factor and key target for developing vaccines, antibody treatments, and phage therapies against K. oxytoca infections. This database will enable researchers to rapidly identify capsule types from genomic data, facilitating surveillance efforts and helping prioritize which capsule types should be targeted for therapeutic development.
⚠️ Preprint – Noch nicht peer-reviewed
Dieser Artikel wurde noch nicht von unabhängigen Experten begutachtet. Die Ergebnisse sind vorläufig und sollten mit Vorsicht interpretiert werden.
The Klebsiella oxytoca Species Complex (SC) represents an emerging healthcare-associated group of opportunistic pathogens. The capsular polysaccharide is a virulence determinant and target for novel vaccines, monoclonal antibodies and phage therapy. In the absence of broadly accessible phenotyping techniques, prediction of capsule types from whole-genome sequence data is critical for understanding capsule diversity and epidemiology, and to prioritise capsule types as targets for novel anti-K. oxytoca SC interventions. Here we present the first comprehensive capsule synthesis locus (K locus) database targeted for the K. oxytoca SC, comprising 88 distinct loci defined by gene content and which is compatible with the rapid genome typing tool Kaptive. The database provides high coverage of publicly available K. oxytoca SC genomes (97.6% of 2,244 genomes, dereplicated from a total of 4,055), and the typing rate is significantly higher than that achieved with the pre-existing Klebsiella K locus database (97.6% vs 50.3%, p <0.0001), which primarily targets the Klebsiella pneumoniae SC. We demonstrate the utility of the novel K. oxytoca SC database by application to three diverse clinical K. oxytoca SC isolate collections (n=61 to 102 genomes each), suggesting a high diversity of K types. The novel K. oxytoca SC K locus database (github.com/klebgenomics/KoSC-surface-antigen-loci) will provide a key resource to support larger systematic studies and ongoing genomics surveillance efforts for the K. oxytoca SC.
Source: A capsule polysaccharide synthesis locus database for the Klebsiella oxytoca Species Complex